Perrigo | PRGO - Operating Profit


Perrigo reported $23.5M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
AbbVie USD 6.72B 1.99B Jun/2026
Abbott USD 2.13B 281M Jun/2026
Bayer EUR 3.53B 2.42B Mar/2026
Bristol-Myers Squibb USD 299M 3.07B Jun/2026
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Corcept Therapeutics USD 41.3M 90.9M Jun/2026
Dr.Reddys Laboratories INR 3.25B 2.36B Jun/2026
Eli Lilly USD 12.46B 2.68B Jun/2026
J&J USD 7.48B 860M Jun/2026
Merck USD 840M 2.72B Jun/2026
Nestle CHF 6.98B 133M Jun/2026
Pacira USD 9.96M 5.33M Jun/2026
Perrigo USD 23.5M 10.1M Jun/2026
Pfizer USD 667M 4.32B Jun/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Prestige Brands USD 75.49M 7M Mar/2026
Reckitt Benckiser GBP 747M 92M Dec/2024
Sanofi EUR 2.38B 449M Jun/2026
Supernus Pharmaceuticals USD -21.04M 14.21M Jun/2026
Teva Pharmaceutical Industries USD 235M 523M Jun/2026
Xeris Pharmaceuticals USD 7.92M 8.86M Mar/2026
Zoetis USD 865M 30M Mar/2026